Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 307
Selected: 0
NCT IDTitle
NCT00896818Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
NCT00027664Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer
NCT07209774Healthspan Connect Programme of Research
NCT00058032CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
NCT02741856Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation
NCT01590160Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma
NCT01685190A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer
NCT05255653Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
NCT06988475DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
NCT00720447Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
NCT00259844Effect of TroVax in Patients Having Colorectal Cancer With Liver Metastases Removed
NCT02272478Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations
NCT05368298SCOOT: Sample Collection for DART
NCT00985868AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors
NCT05991388A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
NCT03327662Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer
NCT03150576Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer
NCT00562068Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma
NCT01737242UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies
NCT01993979A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)
NCT00977210Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients With Advanced Solid Tumors
NCT02724163International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
NCT02530411Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer
NCT03562169The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
NCT00005056Bryostatin 1 In Treating Patients With Progressive Kidney Cancer
NCT04747665Experiences and Perceptions of Colonoscopy and New Technologies
NCT02077569AKT Inhibitor in Oestrogen Positive Breast Cancer
NCT05541601Prospective Cohort for Early Detection of Liver Cancer
NCT00555386Soy, Selenium and Breast Cancer Risk
NCT00829205Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment
NCT02695966EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer
NCT05722886DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
NCT03096054A Phase I Trial of LY3143921 Hydrate in Solid Tumours
NCT05830292Use of DRS Probe and Tracking for In-vivo Application
NCT03410030Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)
NCT01140737A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas
NCT01561911A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment
NCT02330926Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy
NCT00002476Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
NCT04717674[18F]FPIA PET/CT Imaging in Patients With Solid Tumours
NCT00554775WBRT & Erlotinib in Advanced NSCLC and Brain Metastases
NCT02520128A Study of IMRT in Primary Bone and Soft Tissue Sarcoma
NCT01937533Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer
NCT07095517Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
NCT07649525Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level
NCT02042768Observational Study of Glucose Metabolism and How Dialysate Glucose Affects This
NCT02051868International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel
NCT07279454The EAT-FIBRE Study.
NCT00748527Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT05770544DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.